The aim of this study is to learn more about Lipoprotein(a) values (a type of protein in the blood) in people with coronary heart disease (known as Atherosclerotic Cardiovascular Disease [ASCVD]).
Lipoprotein(a) is a particle that carries cholesterol in the blood and is a known risk factor for cardiovascular disease. High levels of Lp(a)are directly associated with a higher risk of cardiovascular events such as heart attacks or aortic stenosis. Unlike other lipid risk factors that can be influenced by diet, exercise, or obesity, Lp(a) levels are inherited and stay stable from childhood. Until more recently, the role of Lp(a) was not well understood and therefore it was not routinely tested for. This study aims to collect data on Lp(a) in ASCVD patients to understand better the distribution of this risk in such patients.
This study is being done to identify the people with a history of myocardial infarction (heart attacks) and/or percutaneous coronary intervention that have an Lp(a) level of at least 90 mg/dL or 200 nmol/L.
For this study, if your Lp(a) value is known, no additional tests or procedures are required beyond what your regular doctor would normally do as part of your routine medical care. If your Lp(a) value is unknown, you will have 1 visit to the study site for data collection and blood collection only.
Reasonable out of pocket expenses incurred through participation in this study will be reimbursed, including travel.
To find out more, contact us on nuth.PRCNewcastle@nhs.net or 0191 282 3655.